Author

Anvi Wadke

Observed names: A. Wadke, Wadke, Anvi

Institutions: North Bristol NHS Trust, Nottingham University Hospitals NHS Trust, Frenchay Hospital, University College London

Observed institutions: North Bristol NHS Trust, Nottingham University Hospitals NHS Trust, Frenchay Hospital, University College London

ORCID: 0009-0009-6846-1034

Observed ORCID: 0009-0009-6846-1034

OpenAlex ID: A5095369024

Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study

2025 · Andrew A Plumb, Gordon Moran, et al. · Inflammatory Bowel Diseases · 14

Acute High Dose Melatonin for Encephalopathy of the Newborn (ACUMEN) Study: a protocol for a multicentre phase 1 safety trial of melatonin to augment therapeutic hypothermia for moderate/severe hypoxic ischaemic encephalopathy

2025 · Raymand Pang, Alyson Macneil, et al. · BMJ Open · 11

A study protocol for a feasibility randomised controlled trial investigating videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in patients with penile cancer (VELRAD)

2024 · Stanley Tang, Clare Akers, et al. · Pilot and Feasibility Studies · 6

Prospective multicentre randomised controlled trial to assess the clinical effectiveness of the novel CirrhoCare digital therapeutic management system: a study protocol

2025 · Olivia Greenham, Kohilan Gananandan, et al. · BMJ Open · 5

Inter- and intra-observer variability of software quantified bowel motility measurements of small bowel Crohn’s disease: findings from the MOTILITY trial

2025 · Maira Hameed, Andrew A. Plumb, et al. · Insights into Imaging · 4

Diffusion-weighted imaging to predict longer-term response in Crohn’s disease patients commencing biological therapy: results from the MOTILITY trial

2025 · Maira Hameed, Stuart A Taylor, et al. · British Journal of Radiology · 4

Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort study

2025 · Shankar Kumar, Andrew Plumb, et al. · Health Technology Assessment · 2

MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn’s disease

2025 · Naomi S. Sakai, Andrew A. Plumb, et al. · Insights into Imaging · 1

Using imaging to improve the prediction of disabling Crohn's Disease

2019 · Anvi Wadke · http://isrctn.com/

A Cancer Research UK phase I trial of adoptive transfer of autologous tumour antigen specific T-cells with pre-conditioning chemotherapy and intravenous interleukin-2 (IL2) in patients with advanced carcinoembryonic antigen (CEA) positive tumours

2012 · Anvi Wadke

Treatment of advanced, epithelial-derived cancer (AEC) with intraperitoneal implantation of agarose-agarose macrobeads (MB) containing mouse renal adenocarcinoma cells (RENCA).

2011 · C. H. Keir, A. J. Ocean, et al. · Journal of Clinical Oncology

Works count: 13

Citation count: 47

H-index: 4

I10-index: 2